Ruben Isacson

Ruben Isacson is a highly experienced professional in the field of pharmacology and biotechnology, currently serving as a Preclinical Assessor at the Medical Products Agency Läkemedelsverket since October 2017. Prior roles include Chief Scientific Officer and Study Director at Adlego Biomedical AB, as well as Senior Research Scientist at AstraZeneca. Ruben began their career as a Research Engineer at Biovitrum AB and held various research positions at NeuroNova AB and Aktivia Science Work AB. Academic qualifications include a PhD in Pharmacology from Karolinska Institutet and an MSc in Biology, specializing in Biotechnology and Molecular Biology from SLU - Swedish University of Agricultural Sciences.